Your cart is empty.
Ion Channels Focused Library

Ion Channels Focused Library

Files to download
Preferred format
Desirable size of the custom library selection
Number of compounds
Amount
Volume
uL
Description
A unique collection of small molecule compounds selected for Ion Channels protein targets
  • Therapeutically relevant 57 ion channels (119 protein sub-families/units targets in total)
  • Recent literature data from 509 research papers and patents published since 2014
  • The most recent (2019 and 2020) X-Ray and Cryo-EM structures from PDB
  • Comprehensive Ion Channels Platform Library : 26,000 compounds

Ion channels are pore-forming proteins that allow the flow of ions across membranes
Physiologically the Ion Channels are regulated by
– voltage, e.g. most Na, K, Ca and some Cl channels are “voltage-gated ion channels”
– intracellular and/or extracellular mediators, e.g. some K and Cl channels, TRP channels, GABA(A) and P2X receptors are “ligand-gated ion channels”
Ion channels are well recognized as important therapeutic targets for diseases of
– the central nervous system (CNS), e.g. sleep disorders, anxiety, epilepsy, pain
– the peripheral nervous system, e.g. anticonvulsant, analgesic, anti-inflammatory
– the cardiovascular system, e.g. ischemia, hypoxic conditions, stroke
Publications
1. J Med Chem 2018(61)8:3641-3659. Discovery of a Potent (4 R5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling. Chen H Volgraf M Do S Kolesnikov A Shore DG Verma VA Villemure E Wang L Chen Y Hu B Lu AJ Wu G Xu X Yuen PW Zhang Y Erickson SD Dahl M Brotherton-Pleiss C Tay S Ly JQ Murray LJ Chen J Amm D Lange W Hackos DH Reese RM Shields SD Lyssikatos JP Safina BS Estrada AA.

2. J Med Chem 2018(61)3:695-710. Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma. Mazur M Olczak J Olejniczak S […] Cousido-Siah A Fadel F
Golebiowski A.

3. J Med Chem 2018(61)1:224-250. Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity. Li B Ni S Mao F Chen F Liu Y Wei H Chen W Zhu J Lan L Li J.

4. J Med Chem 2018(61)3:1355-1374. 3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-36-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702) a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. Ren Q Liu X Yan G Nie B Zou Z Li J Chen Y Wei Y Huang J Luo Z Gu B Goldmann S Zhang J Zhang Y.

5. J Med Chem 2018(61)1:207-223. A Dipolar Cycloaddition Reaction To Access 6-Methyl-4567-tetrahydro-1H-[123]triazolo[45-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate. Chrovian CC Soyode-Johnson A Peterson AA Gelin CF Deng X Dvorak CA Carruthers NI Lord B Fraser I Aluisio L Coe KJ Scott B Koudriakova T Schoetens F Sepassi K Gallacher DJ Bhattacharya A Letavic MA.

6. J Med Chem 2018(61)1:84-97. Phenotypic Optimization of Urea-Thiophene Carboxamides To Yield Potent Well Tolerated and Orally Active Protective Agents against Aminoglycoside-Induced Hearing Loss. Chowdhury S Owens KN Herr RJ Jiang Q Chen X Johnson G Groppi VE Raible DW Rubel EW Simon JA.

7. J Med Chem 2018(61)8:3685-3696. Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis. Menhaji-Klotz E
Hesp KD Londregan AT Kalgutkar AS Piotrowski DW Boehm M Song K Ryder T Beaumont K Jones RM Atkinson K Brown JA Litchfield J Xiao J Canterbury DP Burford K Thuma BA Limberakis C Jiao W Bagley SW Agarwal S Crowell D Pazdziorko S Ward J Price DA Clerin V.

8. J Med Chem 2018(61)1:251-264. 7-Phenoxy-Substituted 34-Dihydro-2H-124-benzothiadiazine 11-Dioxides as Positive Allosteric Modulators of Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency. Goffin E Drapier T Larsen AP Geubelle P Ptak CP Laulumaa S Rovinskaja K Gilissen J Tullio P Olsen LFrydenvang K Pirotte B Hanson J Oswald RE Kastrup JS Francotte P.

9. J Med Chem 2017(60)22:9239-9250. Structure-Based Design and Discovery of New M2 Receptor Agonists. Fish I Stößel A Eitel K Valant C Albold S Huebner H Möller D Clark MJSunahara RK Christopoulos A Shoichet BK Gmeiner P.

10. ACS Med Chem Lett 2017(8)1:133-137. Development of 4-Heteroarylamino-1'-azaspiro[oxazole-53'-bicyclo[2.2.2]octanes] as Nicotinic Receptor Agonists. Hill MD Fang H King
HD Iwuagwu CI McDonald IM Cook J Zusi FC Mate RA Knox RJ Post-Munson D Easton A Miller R Lentz K Clarke W Benitex Y Lodge N Zaczek R Denton R Morgan D Bristow L
Macor JE Olson R.

11. J Med Chem 2017(60)16:7029-7042. Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-13-thiazol--ylbenzenesulfonamide
(PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7. Swain NA Batchelor D […] Storer RI Stupple PA West CW.

12. 25-disubstituted-pyridyl nicotinic ligands and methods of use thereof 2016 US-9303017-B2

13. Substituted pyrazoles as N-type calcium channel blockers 2016 US-9434693-B2
X
X
Send a message
Request a call

Your Name*

Your E-mail*

Company*

Type in your message here…*
* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.


Your Name*

Your Phone*

Company*

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.